Sign in
4

Changes in Ownership

Nuvectis Pharma, Inc. Filed Acc 0001104659-22-063644

Chief Dev. & Ops. Officer bought 300 shares at $16.54 ($4,962)

From the SEC's structured data for this filing

Trades in this filing

Shemesh Shay · Chief Dev. & Ops. Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2022-05-20 Purchase : show line 1 in the form +300 $16.54 $4,962 1,241,435 D
Open-market purchases · 300 sh · avg $16.54 · $4,962
Loading xslF345X03/tm2216562-1_4seq1.xml…